Who is sponsoring NCT06614205?

NCT06614205 is sponsored by Central Hospital, Nancy, France.

What drugs are being tested in NCT06614205?

Interventions in NCT06614205: tumoral dosimetry by scintigraphy.

What condition does NCT06614205 study?

NCT06614205 studies Meningioma of Brain.

Is NCT06614205 still recruiting?

NCT06614205 is currently completed. Last updated 4 March 2025.

Last reviewed 2025-03-04 · How we verify

NCT06614205: DATUM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tumor Absorbed Dose-Response Relationship in Patients Treated With 177Lu-DOTATATE for Meningioma

Completed Last updated 4 March 2025

What this trial tests

trial testing tumoral dosimetry by scintigraphy in Meningioma of Brain in 11 participants. Completed in 25 February 2025.

Timeline

1 November 2024

Primary endpoint
1 January 2025

25 February 2025

Quick facts

Lead sponsor	Central Hospital, Nancy, France
Status	Completed
Study type	OBSERVATIONAL
Enrollment	11
Start date	1 November 2024
Primary completion	1 January 2025
Estimated completion	25 February 2025
Sites	2 locations across France

Drugs / interventions tested

tumoral dosimetry by scintigraphy

Conditions studied

Meningioma of Brain — all drugs for Meningioma of Brain →

Sponsor

Central Hospital, Nancy, France

Who can join

18 and older, any sex, with Meningioma of Brain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The hypothesis for this study is that there is a dose-response relationship in patients treated with 177Lu-DOTATATE for meningiomas.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06614205 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
Last refreshed: 4 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06614205.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing